Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and how are you today? We have returned from a brief moment of mourning, which took us away from our usual routine yesterday, and have awoken to an impressive amount of snow blanketing the Pharmalot corporate campus. This makes for some pretty scenery while we organize the day ahead. Meanwhile, we are brewing that trusty cup of stimulation and invite you to join us, as always, as we dig in - and get ready to dig out. And so, here are some tidbits. Have a grand day and do stay in touch... United Therapeutics Receives A Subpoena For Marketing Practices (Reuters) Shanghai Official Suspended In Connection With Glaxo Probe (ECNS) FDA Panel Backs Takeda Drug For Bowel Disease (Bloomberg News) European Court Delays AbbVie Spat With EMA Over Data Release (Reuters) Novartis May Swap Animal Health Assets Instead Of A Sale (Bloomberg News) India Tells Drugmakers To Reveal Quarterly Pricing Data (Economic Times) Bristol-Myers Drug For Fat Disorder May Work, But May Be Risky (Reuters) Johnson &...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs